20
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Diabetes mellitus

Control and complications

Pages 182-194 | Published online: 17 May 2016

References

  • Marble A. Late complications of diabetes: a continuing challenge. Diabetologia 1976: 12: 193–9
  • Harris MI, Hamman RF, eds. Diabetes in America. Bethesda: Dept of Health and Human Services, 1985 Aug (NIH publication No. 85–1468)
  • Greene DA, Lattimer S, Ulbrecht J, et al. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 1985: 8(3): 290–9
  • Pfeifer MA. Clinical trials of sorbinil on nerve function. Metabolism 1986: 35(4 Suppl 1): 78–82
  • Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988: 318(20): 1315–21
  • Sosenko JM, Miettinen OS, Williamson JR, et al. Muscle capillary basement-membrane thickness and long-term glycemia in Type I diabetes mellitus. N Engl J Med 1984: 311(11): 694–8
  • Raskin P, Pietri AO, Unger R, et al. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus. N Engl J Med 1983: 309(25): 1546–50
  • Colwell JA, Lopes-Virella MF, Mayfield RK, et al, eds. Workshop on insulin and atherogenesis. May 19–20, 1984. Charleston. South Carolina. Metabolism 1985: 34(12 Suppl 1): 1–6
  • Rosenstock J, strowig S, Cercone S, et al. Reduction in cardiovascular risk factors with intensive diabetes treatment in insulin-dependent diabetes mellitus. Diabetes Care 1987: 10(6): 729–34
  • Oakley WG, Pyke DA, Tattersall RB, et al. Long-term diabetes: a clinical study of 92 patients after 40 years. 9 J Med 1974: 63(169): 145–56
  • Krolewski AS, Warram JH, Rand LI, et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987: 317(22): 1390–8
  • Ramsay RC, Goetz FC, Sutherland DE, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988: 318(4): 208–14
  • The Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment: follow-up of the Kroc Collaborative Study. JAMA 1988: 260(1): 37–41
  • Lauritzen T, Frost-Larsen K, Larsen HW, et al. Two-year experience with continuous subcutaneous insulin Infusion in relation to retinopathy and neuropathy. Diabetes 1985: 34(Suppl 3): 74–9
  • Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986: 2(8519): 1300–4
  • Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo Study. Br Med J (Clin Res) 1986: 293(6556): 1195–9
  • Holman RR, Dornan TL, Mayon-White V, et al. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two-year randomised prospective study. Lancet 1983: 1(8318): 204–8
  • Beck-Nielsen H, Richelsen B, Mogensen CE, et al. Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 1985: 8(6): 585–9
  • Hanssen KF, Dahl-Jørgensen K, Lauritzen T, et al. Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 1986: 29(10): 677–84 [erratum. Diabetologia 1986: 29(12): 901]
  • The Diabetes Control and Complications Trial. Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus Justified? N Engl J Med 1988: 318(4): 246–50
  • Cryer PE, Gerich JE. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 1985: 313(4): 232–41
  • Simonson DC, Tamborlane WV, DeFronzo RA, et al. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med 1985: 103(2): 184–90
  • Amiel SA, Tamboriane WV, Simonson DC, et al. Defective glucose counter-regulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987: 316(22): 1376–83
  • White NH, Skor DA, Cryer PE, et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983: 308(9): 485–91
  • The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 1987: 10(1): 1–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.